Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00683475 | A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer | completed | Phase 2 | 138 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01009736 | Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | completed | Phase 1 / Phase 2 | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01574846 | Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer(Vantas) | completed | — | 142 | Orion Corporation, Orion PharmaINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01749774 | Physical Activity and Testicular Cancer | completed | N/A | 13 | Oslo University HospitalOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00459407 | Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2014 | clinicaltrials |
| NCT02257827 | Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | completed | Phase 3 | 220 | Gustavo Viani ArrudaOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00705094 | Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients | completed | — | 30 | AHS Cancer Control AlbertaOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00103194 | Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01714219 | Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy | completed | N/A | 100 | Seoul National University HospitalOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT02237612 | Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer | completed | N/A | 9 | University of Southern CaliforniaOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT01902251 | Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients | completed | Phase 1 | 27 | Astellas Pharma Europe B.V.INDUSTRY | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00801242 | Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer | completed | Phase 3 | 220 | Ferring PharmaceuticalsINDUSTRY | 6 | Sep 3, 2014 | clinicaltrials |
| NCT01177436 | Prostate Cancer Antigen 3 (PCA-3) Gene Project | completed | N/A | 31 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00323882 | Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 75 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00444730 | Urology Database for Outcomes Research | completed | — | 860 | Kenneth Peters, MDOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01484665 | Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening | completed | N/A | 72 | University of MinnesotaOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT01553838 | A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values | completed | N/A | 185 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Aug 19, 2014 | clinicaltrials |
| NCT00476645 | Fulvestrant in Hormone Refractory Prostate Cancer | completed | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT00672594 | Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy | completed | Phase 2 | 30 | Duke UniversityOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00815750 | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | completed | N/A | 147 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT01424930 | A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 25 | Janssen-Ortho Inc., CanadaINDUSTRY | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00424385 | Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC) | completed | Phase 1 | 17 | Oncology Specialists, S.C.OTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01729676 | Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation(FACT) | completed | — | 315 | Ferring PharmaceuticalsINDUSTRY | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00349557 | Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer | completed | Phase 2 | 18 | Benaroya Research InstituteOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00278993 | Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy | completed | Phase 2 | 108 | Eisai Inc.INDUSTRY | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00800813 | Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00956163 | Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01742962 | Prevalence of Neglected Side Effects to Radical Prostatectomy | completed | — | 396 | Copenhagen University Hospital at HerlevOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00919035 | Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients | completed | Phase 2 | 21 | Oncology Specialists, S.C.OTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00305669 | GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer | completed | Phase 1 | 24 | University of California, San FranciscoOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00459654 | A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer | completed | Phase 2 | 64 | BayerINDUSTRY | 2 | Jun 25, 2014 | clinicaltrials |
| NCT00748046 | Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton | completed | Phase 1 | 10 | BayerINDUSTRY | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00337077 | Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 121 | National Cancer Institute (NCI)NIH | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00058253 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT01005225 | Genetic Investigation of Solid Tumors Cohort | completed | — | 25 | Scripps Translational Science InstituteOTHER | 1 | Jun 12, 2014 | clinicaltrials |
| NCT02156869 | Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening(PSAMG) | completed | N/A | 1,170 | University Paris 7 - Denis DiderotOTHER | 1 | Jun 5, 2014 | clinicaltrials |
| NCT00378690 | A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD(ICELAND) | completed | Phase 3 | 706 | Astellas Pharma IncINDUSTRY | 10 | Jun 4, 2014 | clinicaltrials |
| NCT00946920 | A Trial of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 859 | Ferring PharmaceuticalsINDUSTRY | 14 | Jun 2, 2014 | clinicaltrials |
| NCT00054639 | Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00390468 | Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00330161 | Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | May 26, 2014 | clinicaltrials |
| NCT00183924 | Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. | completed | Phase 2 | 20 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00002721 | Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 | 18 | University of New MexicoOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | completed | Phase 2 | 15 | Rutgers, The State University of New JerseyOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01088529 | Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer | completed | Phase 2 | 66 | Cougar Biotechnology, Inc.INDUSTRY | 1 | May 15, 2014 | clinicaltrials |
| NCT00805701 | Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | completed | Phase 4 | 40 | Bay State Clinical Trials, Inc.OTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT00087139 | Ixabepilone in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 124 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00110214 | Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 3 | 1,050 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Oct 16, 2014source: clinicaltrials